Kelly Fahnoe

Kelly Fahnoe

Company: Q32 Bio

Job title: Associate Director – Protein Science


Tissue Localized Inhibition of Complement Activation 4:40 pm

Delivery of targeted bispecific fusion proteins are intended to drive a high local concentration of complement inhibitors in the tissue while reducing systemic complement blockade Bispecific fusion proteins were designed, expressed, and characterized in vitro to show modulation of complement activation over a broad potency range. In vivo studies in rodent preclinical models demonstrate targeting-dependent…Read more

day: Track A - Day 3PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.